Analysis
| Earnings estimate |
Current quarter (Oct 2025) |
Next quarter (Jan 2026) |
Current year (Jan 2026) |
Next year (Jan 2027) |
|---|---|---|---|---|
| Number of analysts | 31 | 30 | 35 | 34 |
| Average estimate | 3.85 | 2.92 | 15.01 | 16.28 |
| Low estimate | 3.70 | 2.81 | 14.80 | 15.50 |
| High estimate | 4.02 | 3.18 | 15.30 | 16.83 |
| Last year EPS | 3.67 | 3.02 | 14.91 | 15.01 |
| Revenue estimate |
Current quarter (Oct 2025) |
Next quarter (Jan 2026) |
Current year (Jan 2026) |
Next year (Jan 2027) |
|---|---|---|---|---|
| Number of Analysts | 29 | 27 | 34 | 32 |
| Avg. estimate | 40.88B | 37.95B | 163.96B | 171.27B |
| Low estimate | 37.82B | 35.52B | 155.91B | 167.90B |
| High estimate | 41.53B | 40.20B | 166.10B | 179.02B |
| Last year sales | 40.22B | 39.70B | 159.51B | 163.96B |
| Sales growth | 0.02 | -0.04 | 0.03 | 0.04 |
| EPS trend |
Current quarter (Oct 2025) |
Next quarter (Jan 2026) |
Current year (Jan 2026) |
Next year (Jan 2027) |
|---|---|---|---|---|
| Current estimate | 3.85 | 2.92 | 15.01 | 16.28 |
| 7 days ago | 3.85 | 2.91 | 15.01 | 16.29 |
| 30 days ago | 3.85 | 2.89 | 15.01 | 16.32 |
| 60 days ago | 3.85 | 2.89 | 15.06 | 16.31 |
| 90 days ago | 3.85 | 2.89 | 15.01 | 16.33 |
| EPS revisions |
Current quarter (Oct 2025) |
Next quarter (Jan 2026) |
Current year (Jan 2026) |
Next year (Jan 2027) |
|---|---|---|---|---|
| Up last 7 days | 12 | 14 | 11 | 6 |
| Up last 30 days | 12 | 13 | 9 | 6 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 7 | 6 | 10 | 14 |
| Growth estimates | |
|---|---|
| Current qtr (Aug 2025) | 0.048% |
| Next qtr. (Nov 2025) | -0.034% |
| Current year (2025) | 0.007% |
| Next 5 years (per annum) | 0.094% |
| Past 5 years (per annum) | 0.113% |